Altaire Pharmaceuticals

Altaire Pharmaceuticals is seeking innovative partnerships to co-develop and commercialize our orphan drug portfolio and novel therapies based on our unique formulation-based intellectual property, enabling us to best meet patient needs in the respiratory disease treatment space. Key therapeutic focus areas include: non-narcotic prescription cough medication and bronchiectasis treatments for both non-cystic fibrosis and cystic fibrosis patient populations.